Literature DB >> 31368770

Randomized controlled trial of d-cycloserine in cocaine dependence: Effects on contingency management and cue-induced cocaine craving in a naturalistic setting.

Matthew W Johnson1, Natalie R Bruner1, Patrick S Johnson1, Kenneth Silverman2, Meredith S Berry1.   

Abstract

Cocaine dependence constitutes a significant public health concern. This randomized, double-blind, placebo-controlled trial tested a novel approach to reducing cocaine use among cocaine-dependent individuals with d-cycloserine, a drug known to enhance learning and some learning-based therapies. Urine samples and cocaine craving were assessed across three phases: induction (Weeks 1-2), treatment (Weeks 3-5; urinalysis-based contingency management plus exposure therapy), and posttreatment (Weeks 6-7). During the treatment phase, either 50 mg of d-cycloserine or placebo was administered after delivery of urinalysis feedback with potential monetary reward and before exposure therapy sessions in naturalistic contexts individually associated with cocaine use. d-cycloserine significantly improved learning on an operant laboratory task. Contingency management significantly reduced cocaine use and craving. d-cycloserine did not significantly affect cocaine use or craving in the treatment phase. Craving significantly increased for the d-cycloserine group during the post treatment phase. Therefore, although the study showed that d-cycloserine was capable of improving learning, enhancement of learning-based therapy was not observed. Moreover, no differences in behavioral measures of cocaine demand (cocaine purchasing task) or monetary or sexual delay discounting were observed across phases or between groups in any phase. These results are somewhat consistent with previous findings suggesting that d-cycloserine administration increases cocaine craving, although they differ from other findings showing that d-cycloserine administration reduces alcohol or nicotine cravings. Methodological variables (e.g., guided vs. unguided exposure therapy sessions, length of extinction exposure) likely play a role in dissimilar findings observed across studies. (PsycInfo Database Record (c) 2020 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31368770      PMCID: PMC6994347          DOI: 10.1037/pha0000306

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  67 in total

1.  Conducting exposure treatment in multiple contexts can prevent relapse.

Authors:  L M Gunther; J C Denniston; R R Miller
Journal:  Behav Res Ther       Date:  1998-01

2.  D-cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor blockade in rats.

Authors:  M Ohno; S Watanabe
Journal:  Eur J Pharmacol       Date:  1996-12-30       Impact factor: 4.432

3.  D-cycloserine facilitates extinction but does not eliminate renewal of the conditioned emotional response.

Authors:  Amanda M Woods; Mark E Bouton
Journal:  Behav Neurosci       Date:  2006-10       Impact factor: 1.912

4.  Effects of D-cycloserine on extinction of conditioned freezing.

Authors:  Lana Ledgerwood; Rick Richardson; Jacquelyn Cranney
Journal:  Behav Neurosci       Date:  2003-04       Impact factor: 1.912

5.  Age- and dose-dependent facilitation of associative eyeblink conditioning by D-cycloserine in rabbits.

Authors:  L T Thompson; J F Disterhoft
Journal:  Behav Neurosci       Date:  1997-12       Impact factor: 1.912

6.  D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation.

Authors:  Elizabeth J Santa Ana; Bruce J Rounsaville; Tami L Frankforter; Charla Nich; Theresa Babuscio; James Poling; Kishorchandra Gonsai; Kevin P Hill; Kathleen M Carroll
Journal:  Drug Alcohol Depend       Date:  2009-07-09       Impact factor: 4.492

7.  Facilitation of extinction of operant behaviour in mice by D-cycloserine.

Authors:  David Shaw; Kelly Norwood; Kim Sharp; Lauren Quigley; Stephen F J McGovern; Julian C Leslie
Journal:  Psychopharmacology (Berl)       Date:  2008-09-11       Impact factor: 4.530

8.  Spacing extinction trials alleviates renewal and spontaneous recovery.

Authors:  Gonzalo P Urcelay; Daniel S Wheeler; Ralph R Miller
Journal:  Learn Behav       Date:  2009-02       Impact factor: 1.986

9.  Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants.

Authors:  Michael W Otto; Shawnee L Basden; R Kathryn McHugh; Kathleen M Kantak; Thilo Deckersbach; Corinne Cather; Donald C Goff; Stefan G Hofmann; Angela C Berry; Jasper A J Smits
Journal:  Psychother Psychosom       Date:  2008-11-18       Impact factor: 17.659

10.  A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.

Authors:  Melissa M Norberg; John H Krystal; David F Tolin
Journal:  Biol Psychiatry       Date:  2008-03-07       Impact factor: 13.382

View more
  2 in total

1.  Sexual discounting: A systematic review of discounting processes and sexual behavior.

Authors:  Matthew W Johnson; Justin C Strickland; Evan S Herrmann; Sean B Dolan; David J Cox; Meredith S Berry
Journal:  Exp Clin Psychopharmacol       Date:  2020-10-01       Impact factor: 3.157

2.  Facilitative effects of environmental enrichment for cocaine relapse prevention are dependent on extinction training context and involve increased TrkB signaling in dorsal hippocampus and ventromedial prefrontal cortex.

Authors:  Margaret H Hastings; Jamie M Gauthier; Kyle Mabry; Audrey Tran; Heng-Ye Man; Kathleen M Kantak
Journal:  Behav Brain Res       Date:  2020-03-16       Impact factor: 3.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.